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The Wnt/b-catenin pathway is evolutionary con-
served signaling system that regulates cell differenti-
ation and organogenesis. We show that endothelial
specific stabilization of Wnt/b-catenin signaling
alters early vascular development in the embryo.
The phenotype resembles that induced by upregula-
tion of Notch signaling, including lack of vascular
remodeling, altered elongation of the intersomitic
vessels, defects in branching, and loss of venous
identity. Both in vivo and in vitro data show thatb-cat-
enin upregulates Dll4 transcription and strongly
increasesNotch signaling in the endothelium, leading
to functional and morphological alterations. The
functional consequences of b-catenin signaling
depend on the stage of vascular development and
are lost when a gain-of-function mutation is induced
at a late stage of development or postnatally. Our
findings establish a link between Wnt and Notch
signaling in vascular development. We propose that
early and sustained b-catenin signaling prevents
correct endothelial cell differentiation, altering
vascular remodeling and arteriovenous specification.
INTRODUCTION
The Wnt canonical signaling pathway regulates fundamental
aspects of development including cell-fate specification, prolif-
eration, survival, and overall organogenesis (for review, see
Angers and Moon, 2009; Clevers, 2006; Dickinson and
McMahon, 1992; Junghans et al., 2005; Klaus and Birchmeier,
2008). Wnt proteins are a large family of secreted signaling
molecules that signal through binding to a coreceptor complex
formed by the seven-pass transmembrane proteins of the
frizzled (Fzd) family and the lipoprotein receptor related 5/6
(Lrp5/6) proteins. This interaction leads to inactivation of
a destruction complex that includes glycogen synthase938 Developmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier Ikinase-3b (GSK-3b), the scaffolding protein axin, and adeno-
matosis polyposis coli (APC). The complex phosphorylates b-
catenin and targets it for ubiquitin-proteasome-mediated
degradation. In the presence of Wnt signaling, b-catenin is
not phosphorylated and is therefore free to translocate to the
nucleus and modulate cell transcription. b-catenin also links
cadherins at cell-to-cell adherens junctions and stabilizes their
interaction with the cytoskeleton.
It has been reported that canonical Wnt pathway may
regulate cardiac and vascular development in the embryo (for
review, see Goodwin and D’Amore [2002] and Parmalee and
Kitajewski [2008]). Endothelial specific deletion of b-catenin
alters the development of the embryonic vasculature and
results in early lethality in utero at embryonic day (E)12.5
(Cattelino et al., 2003). The vessels show changes in vascular
lumen, defects of vascular remodeling, and diffuse hemor-
rhages in different regions of the vascular tree. Furthermore,
loss of b-catenin causes defective endocardial cushion and
cardiac valve development due to altered endothelial mesen-
chymal transformation (Liebner et al., 2004). In absence of
b-catenin, endothelial adherens junctions present a different
molecular organization, which may contribute to vascular
fragility. However, loss of Wnt signaling can also play a role
in the observed phenotype. Consistently, ablation of Fzd5
(Ishikawa et al., 2001) and Wnt2 (Monkley et al., 1996) leads
to a defective placenta vascularization and, in the case of
Fzd5, also to defective remodeling of the yolk sac vasculature
after E10.5. Furthermore, Wnt7b is responsible for hyaloid
vessel regression in the retina (Lobov et al., 2005), and the
binding of norrin to Fzd4 plays an important role in angiogen-
esis of the eye and the ear through stabilization of b-catenin
(Xu et al., 2004; Ye et al., 2009). Finally, the differentiation of
brain microvasculature to acquire blood brain barrier character-
istics requires Wnt signaling and b-catenin transcriptional
activity (Daneman et al., 2009; Liebner et al., 2008; Stenman
et al., 2008).
Wnt cooperates frequently with the Notch signaling pathway in
different cellular systems such as hemopoietic stem cells and
heart development (Cohen et al., 2008; Grego-Bessa et al.,
2007); however, little is known about the cooperation of Wnt
and Notch in vascular development.nc.
Figure 1. Wnt/b-Catenin Signaling Is Active in Newly Forming Vessels in the Mouse Embryo
(A–H) Confocal analysis of sectioned (A–D) and whole-mounted (E–L) E9.5 BAT-gal embryos double stained for b-galactosidase (green), to detect b-catenin
induced expression of the Lac-Z reporter construct, and for PECAM (red) to detect the endothelium. In BAT-gal embryos, double positive cells (arrowheads)
were found within the branchial arteries ([A and B], [B] represents the indicated area in [A]), the dorsal aorta and vitelline artery ([C and D], [D[ represents the indi-
cated area in [C]), (E) cardial vein, (F) ISV, (G) tail, and (H) yolk sac microvasculature.
(I–L) In b-catenin GOF/BAT-gal embryos, an increased number of b-galactosidase and PECAM double-positive cells (I)–(L) were found throughout, the vascular
tree compared to (E)–(H) control embryos. Representative single optical sections are shown. Control, n = 5; GOF, n = 4. Scale bars = 100 mm.
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aspects of endothelial cells (ECs) function such as growth,
migration, lumen formation, and arteriovenous determination
(Hellstrom et al., 2007; Hofmann and Iruela-Arispe, 2007;
Lawson et al., 2001; Phng and Gerhardt, 2009; Roca and Adams,
2007; Suchting et al., 2007; Thurston et al., 2007). Recent studies
in several experimental models show that this signaling pathway
acts by limiting vascular sprouting. Suppression of Notch
signaling by different tools markedly augments vascular density,
branching, and hyperfusion of the capillary network.
In this work, we have studied endothelial-specific b-catenin
gain-of-function (GOF) mutant mice to obtain a more comprehen-
sive idea of the role of canonical Wnt signaling in ECs and to better
define the mechanism of action of this pathway. We report that
theseb-catenin GOF mutant embryos die in utero withmajor alter-
ations of vascular development. Vessels were unable to sprout
and branch correctly, presented altered lumen, and showed
a strongly affected arterial-venous specification. qRT-PCR anal-
ysis of ECs isolated from mutant embryos showed a significant
increase in Dll4/Notch signaling. Isolated and cultured ECs
expressing the same b-catenin GOF mutation also showed
a strong increase in Dll4/Notch signaling accompanied by
reduced sprouting activity. Additionally, chromatin immunopre-Develcipitation and luciferase reporter assays showed b-catenin
binding to the Dll4 promoter. These data determine a sequential
and direct link between b-catenin and Notch signaling systems
to tune ECs differentiation and vascular morphogenesis.
RESULTS
Wnt/b-Catenin Signaling Is Detectable during
Embryonic Vascular Development
We first examined whether b-catenin signaling could be
detected in newly forming vessels in the mouse embryo. Using
BAT-gal reporter mice for Wnt/b-catenin signaling (Maretto
et al., 2003), we observed b-catenin induced LacZ-reporter
activity in ECs starting from E9.5 in several regions of the
vascular tree. Confocal analysis of sectioned and whole-
mounted BAT-gal embryos revealed ECs stained with b-galacto-
sidase nuclei within the branchial arteries, (Figures 1A and 1B),
dorsal aorta (DA), vitelline artery, umbilical vein (Figures 1C and
1D), caval vein, intersomitic vessels, tail microvasculature
(Figures 1E–1G), and yolk sac microvasculature (Figure 1H).
Additionally, b-galactosidase-positive ECs were also found
within the endocardium and perineural vascular plexus, as re-
ported previously (Daneman et al., 2009; Liebner et al., 2004,opmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier Inc. 939
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found throughout the vascular tree, they were four times more
abundant within the vessels of the tail compared to the upper
body.
Endothelial b-CateninDex 3 Recombination Induces
Embryonic Lethality
To understand the functional role of b-catenin signaling during
vascular development, we selectively activated b-catenin tran-
scriptional activity in ECs by crossing b-cateninlox(ex3)/lox(ex3)
mice (Harada et al., 1999) with Tie2-Cre (Kisanuki et al., 2001)
or VE-cadherin-Cre (Alva et al., 2006) transgenics. The recom-
bined mutant b-cateninDex3 lacks the exon 3 domain and cannot
be phosphorylated and subsequently ubiquitinated and
degraded in proteasomes, therefore it is free to translocate
to the nucleus and activate cell transcription functioning as
a GOF mutant. The ability of Tie2-Cre to recombine the floxed
allele in the endothelium was tested by genomic PCR from
embryo extracts. As reported in Figure S1 (available online) the
b-cateninDex3 allele was detected only in embryos expressing
Tie2-Cre (Figure S1C) or VE-cadherin-Cre (data not shown). Fur-
ther support that an efficient recombination of the b-cateninDex3
allele was achieved and provided a robust b-catenin GOF pheno-
type, was given by a 4-fold increase in b-galactosidase reporter
positive ECs throughout the vascular tree of b-catenin GOF
embryos intercrossed with BAT-gal reporter mice compared to
control embryos, 27.3 versus 6.8 reporter positive ECs per
section, (compare Figures 1I–1L with Figures 1E–1H). Further-
more, cultured b-catenin GOF mutants ECs presented an effec-
tive recombination of the floxed gene (Figure S1C). No pup with
endothelial b-cateninDex3/wt/Tie2-Cre+, or VE-cadherin-Cre+ was
born (Figure S1A). b-catenin GOF mutants were morphologically
indistinguishable from control embryos (littermates that had
not inherited the complete set of alleles) up to E8.5 . However,
100% of the embryos died within E11.5 and E12.5 (Figure S1A).
The intercross with either Tie2-Cre or VE-cadherin-Cre trans-
genics gave essentially the same lethality and embryonic pheno-
type, therefore, for the experiments described below, we focused
on one mutant only i.e., b-cateninDex3/wt/Tie2-Cre+ (referred to as
b-catenin GOF mutant from here on).
Vascular Defects in Endothelial b-Catenin GOF Mutants
At E9.5, b-catenin GOF embryos were smaller and the vascular
pattern was strongly defective in several regions of the vascular
tree (Figure 2B). Intersomitic vessels (ISV) in both the occipital
and trunk regions failed to elongate correctly and branching
was severely altered. Irregular blind ending vessels and regions
of vascular fusion and lacunae could be observed (compare
Figures 2A and 2B, Figures 2D and 2E, and Figures 2G and
2H). A closer analysis (Figure S2) highlights strong reduction in
the length of the ISV, and the absence of a perineural vascular
plexus due to lack of correct branching and remodeling of small
vessels in that region.
For comparison, we studied loss-of-function (LOF) mutants of
endothelial b-catenin described in detail in previous work
(Cattelino et al., 2003). Analysis of these embryos, which at this
early stage of development are still viable, revealed an opposite
phenotype as compared to b-catenin GOF mutants with hyper-
branching morphology at the perineural vascular plexus in940 Developmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier Isome regions of the trunk (compare Figures 2G–2I).
Quantification of the observed modifications showed a signifi-
cant decrease in ISV length and branch points and an increase
in ISV lumen size in GOF mutants (Figures 2J–2L) and increased
ISV branching in LOF mutants (Figure 2L). Vascularization of the
head (Figures 2D and 2E and Figures 4F and 4G) and yolk sac
(Figures 4H and 4I) was also affected severely by b-catenin stabi-
lization. Blood vessels in the perineural vascular plexus and the
yolk sac did not undergo remodeling, and large arteries and
veins were essentially missing. The vascular phenotype of b-cat-
enin GOF mutants further progressed until E10.5, and the inter-
somitic, head, and tail vessels showed several areas of degener-
ation, regression, and disconnection (Figures S3A–S3H).
To investigate the degree of arterial-venous specification in
b-catenin GOF mutants, we crossed b-cateninlox(ex3)/lox(ex3)
mice with LacZ reporter strains to detect expression of EphB4,
marking veins (Gerety et al., 1999), or ephrin-B2,marking arteries
(Wang et al., 1998). Recombination of b-cateninDex3 by crossing
with Tie2-Cre transgenics revealed that the expression of EphB4
was strongly downregulated throughout the venous compart-
ment of b-catenin GOF embryos as compared to controls
(Figures 3A and 3C), indicating loss of endothelial venous iden-
tity. Ephrin-B2 was expressed at high levels all over the arterial
compartment in b-catenin GOF embryos (Figure 3D), and no
macroscopic differences could be observed when compared
to control embryos (Figure 3B). However, detailed analysis of
tissue sections showed that ECs expressing ephrin-B2 could
be found both in arteries and veins of b-catenin GOF mutants
as shown in Figures 3E–3H, where both ECs of the DA and ante-
rior cardinal vein (ACV) expressed ephrin-B2, indicating the
establishment of arterial cell identity in the venous compartment
of the mutant embryo. This finding resembles the phenotype
previously found in endothelial specific Notch-signaling GOF
embryos (Kim et al., 2008; Trindade et al., 2008), where ephrin-
B2 expressing cells, normally only found in the arteries, also
could be found in the ACV. Furthermore, as reported in Figures
3I–3L, serial sections from the region where the ACV connects
to the sinus venosus showed that the DA fused with the ACV
b-catenin GOF embryos, leading to a bypass circulation from
DA to the sinus venosus. The presence of this type of shunt is
typical of conditions where arterial-venous identity is lost.
We counted the ratio of Ki67-positive ECs within the DA and
ACV in tissue sections of b-catenin GOF and control embryos
and no significant difference was found (0.18 ± 0.04, percentage
increase in the b-catenin GOF over the control). The level of
apoptosis detected within the embryo vasculature was not
significantly modified (Figure S7).
Stabilization of b-Catenin Induces Notch Signaling
The vascular phenotype observed in b-catenin GOF mutant
embryos was similar to that observed in Dll4/Notch GOF embryos
(Trindade et al., 2008); we therefore tested whether b-catenin
stabilization was coupled to increase in Notch signaling in these
embryos. qRT-PCR analysis of embryo extracts showed that
most EC markers were not modified significantly including pan-
EC markers such as PECAM or VE-cadherin (Figure S4A).
As expected, Axin2 (Figure 4A), which is a sensitive downstream
target ofb-catenin transcriptional activity, was strongly increased.
We also found a consistent and marked augmentation of Dll4 andnc.
Figure 2. Endothelial b-Catenin GOF Mutation Strongly Affects Vascular Development
(A–I) Whole-mount PECAM immunofluorescence staining of E9.5 control (somites n. 24-26) (A, D, and G), b-catenin GOF (B, E, and H), and LOF (C, F, and I)
embryos. In b-catenin GOF embryos, the vascular pattern was strongly defective in several regions of the vascular tree. ISV in the trunk failed to elongate correctly
and branching was severely altered. Irregular blind ending vessels and regions of vascular fusion and lacunae could be observed. The head vasculature did not
undergo remodeling (D and E). LOF mutants showed a hyperbranched morphology at the perineural vascular plexus (compare [G] and [I]).
(J–L) Quantitation of length, lumen size, and branch point of the ISV in the trunk of control, GOF, and LOF embryos. The dotted lines in (G)–(I) indicate the area of
quantification. Error bars represent SD; p values are <0.05 (*) and <0.01 (**) by Student’s t test. Scale bars = 1000 mm in (A)–(C); 200 mm in (D)–(I).
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icant increase in Notch signaling in these embryos. Conversely,
Notch1 and 4 and Jag1 remained essentially unchanged
(Figure 4A). As these data were obtained from total embryoDevelextracts, we could not discriminate whether the increase in Notch
signaling was specific for ECs. Therefore, qRT-PCR analysis was
also carried out on ECs freshly isolated from E9.5 embryo cell
suspensions (Figure 4B). Consistent with the whole-embryoopmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier Inc. 941
Figure 3. Endothelial b-Catenin GOF Mutation Prevents Venous Differentiation and Promotes Vascular Arterialization
b-catenin GOF embryos were crossed with EphB4 and ephrin-B2 LacZ reporter mice to investigate venous and arterial specification, respectively. In b-catenin
GOF embryos (C), the expression of EphB4 was markedly downregulated throughout the venous compartment compared to (A) control embryos, indicating
reduced venous specification in the b-catenin GOF embryos. Macroscopic analysis of the ephrin-B2 expression showed an intense staining throughout the arte-
rial compartment of both (B) control and (D) b-catenin GOF mutants embryos. Confocal analysis of cryosections showed that in addition to the DA and arterioles,
ephrin-B2 expressing cells could also found within the ACV in b-catenin GOF mutants ([G] and magnified area in [H]) but not in control ([E] and magnified area in [F])
embryos. Control, n = 2; GOF, n = 2 embryos. Serial sections further revealed the presences of arteriovenous shunts (arrowhead) in the region where the ACV
connects to the sinus venosus in seven of eight b-catenin GOF (K) and (L) but not in (I) and (J) control embryos. Control, n = 3; GOF, n = 8 embryos. Scale bars = 1
mm in (A)–(D); 50 mm in (E)–(L).
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icantly higher levels of Dll4, Hey1, and Hes. Hey2 was undetect-
able and did not increase in b-catenin GOF cells, whereas the
downstream target of Notch signaling Nrarp was increased
(Phng et al., 2009). Conversely, when b-catenin expression was
abrogated as in LOF mutants, Hes1, Dll4, and Nrarp were signifi-
cantly reduced whereas EphB4 was increased (Figure 4C).
To directly test whether b-catenin GOF mutation in vivo could
increase Notch signaling we crossed TNR1 reporter mice
(expressing a transgene composed of CBF-1 response element
with four CBF-1 binding sites and a minimal SV40 promoter
followed by an enhanced green fluorescent protein, GFP)
(Duncan et al., 2005) with b-cateninDex3/Tie2-Cre mutants. ECs
were freshly isolated and qRT-PCR analysis of GFP expression
was carried out. ECs from TNR1/b-catenin GOF mutants at
E9.5 showed 40% increase in GFP as compared to control
embryos, supporting the idea of increase in Notch signaling on
b-catenin stabilization in the embryo.942 Developmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier ITo further prove the role of Notch activation in the observed
phenotype, we treated pregnant mice with ag-secretase inhibitor
(DAPT) to inhibit Notch signaling in the embryos. Although we
used relatively low doses of the drug to avoid embryo toxicity,
we could see a partial but significant rescue of the phenotype in
the b-catenin GOF mutant embryos. qRT-PCR analysis of ECs
freshly isolated from DAPT treated embryos showed a normaliza-
tion of the expression of the venous markers EphB4 and COUP-
TFII, whereas no effect was detected on the level of ephrin-B2
expression (Figure 4D). Furthermore, analysis of both the head
(Figures 4F, 4G, 4J, and 4K) and yolk sac vasculature (Figures 4H,
4I, 4L, and 4M) showed that the DAPT treatment improved the level
of vascular remodeling and the formation of both large arteries and
veins as indicated by a 4-fold increase in length of the major vitelline
vessels (Figure 4E and highlighted in Figures 4H–4M).
We then intercrossed transgenic lines, allowing endo-
thelial-specific and tamoxifen-inducible Cre-recombination,
(Cdh5-CreERT2) (Sorensen et al., 2009) with b-cateninlox/lox,nc.
Figure 4. Endothelial b-Catenin GOF Mutation Upregulates Notch Signaling
qRT-PCR analysis from (A) whole embryos (E9.5), and (B–D) Dynabeads isolated ECs. The RNA level obtained for controls was set to 1, and the ratio for b-catenin
GOF versus controls or b-catenin LOF versus controls is shown for each gene.
(A–C) Data show that several members of the Notch signaling pathway are upregulated by in vivo endothelial b-catenin GOF mutation and reduced in the absence
of b-catenin. Error bars represent SD. Data are means of four experiments carried out in triplicate. p values are <0.05 (*) and <0.01 (**) by Student’s t test.
(D) The g-secretase inhibitor (DAPT) treatment of GOF embryos rescues the reduction of venous markers induced by the b-catenin GOF to control values. Error
bars represent SD. Control n = 10, GOF untreated n = 8, GOF DAPT treated n = 8 embryos. p value is <0.01 (**) by Student’s t test.
(E) DAPT treatment of GOF embryos improve vascular remodeling. The length of the major vitelline vessels was defined as continuous large arteries and veins with
a diameter >20 mm; untreated embryos n = 8; DAPT treated embryos n = 4 means ± SEM; p value is < 0.01 (**) by Student’s t test. Confocal analysis of PECAM
stained whole-mounted (F, G, J, and K) E9.5 embryos and (H, I, L, and M) yolk sacs, (F–I) untreated, and (J–M) treated with DAPT. The head vasculature of b-cat-
enin GOF embryos lacked remodeling and formation of large veins (box in [G]) as compared to control embryos (box in [F]). Control, n = 10; GOF, n = 10 embryos.
DAPT treatment, starting at E7.5, partially reversed the b-catenin GOF phenotype and promoted remodeling and formation of both large arteries and veins (box
in K) compared to untreated b-catenin GOF embryos (box in [G]). DAPT treatment did not affect the development of the head vasculature in control embryos,
compare (J) to (F). Yolk sacs of (H and I) untreated embryos and (L and M) DAPT treated embryos. b-catenin GOF embryos lacked remodeling of the yolk sac
vasculature and formation of large vessels (compare [I] and [H]). A transient establishment of large vessels (red line in [I]) could be observed before they regressed.
Control, n = 10; GOF, n = 10 embryos. DAPT treatment partially reversed the b-catenin GOF phenotype by promoting remodeling and formation of both larger
arterial (red lines) and venous (green lines) vessels (M) compared to (I) untreated b-catenin GOF embryos. The DAPT treatment did not affect the development of
the yolk sac vasculature in control embryos (L) compared to (H) (red and green lines correspond to arteries and veins, respectively). Control, n = 8; GOF, n = 4
embryos. Scale bars = 100 mm (F, G, J, and K); 500 mm (H, I, L, and M).
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b-catenin stabilization or deletion on the developing retinal
vasculature, we initiated tamoxifen treatments of mutant litters
at postnatal day (p)1 or p3 and carried out analysis at p5–6
(Figures S5A and S5I). In both mutants, the radial expansion of
the retinal vasculature was reduced as compared to controls,
whereas the general morphology was similar (Figures S5B,
S5C, S5J, and S5K). Quantification of the number of tip cells
and filopodia per length of the vascular front did not reveal any
difference in the two conditions (Figures S5B–S5P). Vascular
density was reduced in LOF mutants (data not shown), in agree-
ment with previous reports (Phng et al., 2009).
Furthermore, b-catenin GOF mutation was induced at late
stages of embryonic development by treating pregnant mutant
females with tamoxifen at E9.5 (Figure S5Q) and analyzing their
vasculature up to E14.5 when recombination is expected to
reach the highest level. We could not observe major differences
in arteriovenous morphology and specification (data not shown).
qRT-PCR analysis, carried out on freshly isolated ECs from
b-catenin GOF and control embryos at E12.5 and E14.5 respec-
tively, show only a small and not significant increase in Dll4 and
downstream Notch effectors (Figure S5R) induced by b-catenin
GOF mutation. Overall these observations indicate that endo-
thelial cells are sensitive to b-catenin GOF mutation only at early
stages of vascular development. At later stages, when arteriove-
nous identity is largely determined, the effect of sustained b-cat-
enin signaling is lost.
b-Catenin GOF Mutation in Cultured ECs Affects Cell
Sprouting
To further study the mechanism of action of b-catenin at a cellular
and molecular level and to avoid indirect alterations due to
defective organ perfusion, we isolated and cultured ECs from
b-cateninlox(ex3)/wt/Cre embryos. Recombination was induced
in vitro by treating the cells with an adeno-Cre vector (Cattelino
et al., 2003) (Figure S1C). qRT-PCR analysis of these cells
showed a picture largely comparable to that obtained in the
freshly isolated endothelium from b-catenin GOF embryos
(Figure S4C). Axin2, Dll4, and Hey1 were strongly increased.
Hey2, Hes, and Notch1 were not significantly changed whereas
a small increase in Jag1 was detected.
Confluent b-catenin GOF ECs presented different morphology
on recombination (compare Figures 5E and 5G): actin staining
showed short stress fibers and irregular intercellular contacts
whereas control cells were more elongated with longer and
more organized stress fibers. Staining of b-catenin was concen-
trated at intercellular junctions in control cells but it was intense
also in the nuclei in b-catenin GOF mutant cells indicating higher
transcriptional signaling (compare Figures 5A and 5C). When
a wound was induced in the cell monolayer, control and b-cate-
nin GOF cells migrated into the empty space with different
morphologies. Whereas control ECs formed several sprouting
pseudopodia and filopodia (Figure 5F, arrowheads), b-catenin
GOF mutant cells presented peripheral ruffles and lamellipodia
at the front instead of filopodia (Figure 5H, arrows; Movies S1
and S2). In b-catenin GOF mutant cells and, to a much lower
degree, in control cells, nuclear staining of b-catenin was
increased in cells located at the migrating front compared to
confluent cells (Figures 5A–5D).944 Developmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier ITo test whether, similarly to b-catenin GOF embryos, the
increase in b-catenin signaling was accompanied by increase
in Notch signaling, we stained the ECs with an antibody against
the intracellular domain of Notch1 (NICD), which is released from
the membrane and translocates to the nucleus on Notch activa-
tion (Artavanis-Tsakonas et al., 1999; Bray, 2006). As shown in
Figure 5J, we found that Notch signaling was increased in control
cells located at the migrating front as compared to confluent
cells (Figure 5I). A similar pattern was also found in b-catenin
GOF mutant cells but to a much stronger degree (Figure 5L). Inhi-
bition of Notch signaling by DAPT treatment increased control
cell sprouting into the wound (Figures 5Q and 5R). In addition,
DAPT treatment of b-catenin GOF mutant cells partially recov-
ered the mutant phenotype, cells showed filopodia (arrowheads)
and higher sprouting activity (Figures 5S and 5T).
Finally, we infected the cells with a construct encoding the
intracellular (IC) domain of Notch1 (N1IC) engineered into pHyTc
retroviral vector. As reported in Figures S6E and S6F when we
focused on the infected cells at the front by staining with an
anti-HA-Tag antibody, constitutive Notch signaling induced
peripheral ruffles and lamellipodia similarly to b-catenin GOF
mutant cells. Furthermore neither b-catenin nor Notch GOF
mutations did not change cell proliferation (Figure S6G).
b-Catenin Increases Notch Activity through Its
Transcriptional Activity
To investigate whether the effect of b-catenin in inducing Notch
activation and changes in cell morphology were mediated by its
transcriptional activity, b-catenin GOF mutant cells were in-
fected with a dominant-negative TCF4 mutant (dnTCF4) able to
abrogate b-catenin transcriptional activity (Liebner et al., 2008).
In these cells the transcription of both Axin2 and Dll4 were
strongly reduced and Notch signaling was abrogated (Figures
6A and 6B). These cells express both Notch 1 and 4 as receptors
and the effect of Dll4 reduction was apparent when they were in
reciprocal contact as shown in the Figure 6B. To further prove
that Notch signaling was increased by cell contact with b-catenin
GOF mutant ECs, a coculture system with HeLa cells transfected
with Notch 1 was used. As reported in Figure S6H b-catenin GOF
endothelial cells increased NICD fluorescence intensity in the
nucleus of HeLa transfected cells.
In addition, infection of ECs with a transcriptionally active
b-catenin mutant (LefDN-bCTA) (Taddei et al., 2008) unable to
bind cadherins, did reproduce the morphological changes
induced by b-catenin GOF mutation, whereas a mutant able to
link cadherins but unable to translocate to the nucleus (DC-Far)
(Hagen et al., 2004) did not (Figures S6C and S6D).
To investigate whether b-catenin could interact directly with
Dll4 promoter, we carried out chromatin immunoprecipitation
assay (ChIP). Two consensus sequences for TCF-b-catenin
binding sites were identified in the Dll4 promoter: Region 1, posi-
tion 4137/4121; Region 2, position 722/706 (Figure 6C).
b-catenin associates to Dll4 promoter in both confluent and
wounded b-catenin GOF cells (Figures 6D–6G). Interestingly, in
control cells, the binding of b-catenin to the Dll4 promoter could
be detected in wounded monolayers only supporting the
concept that Notch signaling is increased, through b-catenin
transcriptional activity, when junctions are weaker (Figures 6F
and 6G). To further test the specificity of b-catenin interactionnc.
Figure 5. b-Catenin GOF Mutation in Cultured ECs Affects Cell Sprouting and Pattern of Migration
Cultured ECs b-cateninlox(ex3)/wt/Cre were infected with adeno vector-expressing Cre-recombinase to obtained ECs line b-cateninDex3/wt (GOF). Confluent cells
were wounded to produce a cell-free zone. Immunofluorescence analysis of cells stained with (A–D) anti-b-catenin antibody and (E–H) phalloidin in confluent and
wounded monolayer. b-catenin was concentrated in the nucleus in (C and D) b-catenin GOF mutant cells and in (B) control cells at the migrating front. Pseudo-
podia and filopodia are present in ‘‘migrating’’ control cells (arrowheads in [F]). In contrast, b-catenin GOF mutant cells present peripheral ruffles at the front
(arrows in [H]) and no filopodia. (I–L) Nuclear NICD staining was strongly increased in (J) migrating control cells and more markedly in (L) b-catenin GOF cells.
Dashed lines (J and L) indicate the migrating front. NICD nuclear staining was reduced in the presence of DAPT in both control and b-catenin GOF cells (M,
N, O, and P). DAPT treatment induced more elongated filopodial protrusions ([R], arrowheads) in control cells and recovered a sprouting morphology and
long actin fibers in b-catenin GOF cells (arrowheads in [T]). Scale bars = 20 mm.
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transfecting ECs with a construct where luciferase is under the
control of Dll4 promoter (Seo et al., 2006) or the same promoter
with a point mutation in the TCF-b-catenin binding site of theDevelRegion 2. As reported in Figures 6H and 6I both Wnt3a and
b-catenin GOF mutation increased Dll4 expression and lucif-
erase reporter activity only in the wild-type promoter sequence
but not in the mutant.opmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier Inc. 945
Figure 6. b-Catenin Increases Notch Signaling through Its Transcriptional Activity
(A) qRT-PCR analysis of Axin2 and Dll4 mRNA levels in b-catenin GOF ECs shows a significant inhibition of Axin2 and Dll4 upregulation by cell infection with
dnTCF4. Error bars represent the SD; data are means of three experiments carried out in triplicate. p value is <0.01 (**) by Student’s t test.
(B) dnTCF4 abrogates the effect of b-catenin GOF mutation on nuclear NICD staining. Green nuclei show an anti-HA-Tag staining of dnTCF4 confirming infection
of target cells. Scale bar = 20 mm.
(C) ChIP analysis shows association of b-catenin to Dll4 promoter region. The positions of the putative Tcf-b-catenin binding site, T, are indicated. CDS, coding
sequence.
(D-G) Chromatin from control and b-catenin GOF cells was immunoprecipitated with b-catenin antibody and qRT-PCR on Region 1 and Region 2 was carried out.
Quantitative and qualitative analysis on b-catenin-bound chromatin immunoprecipitated from confluent (D and E) and wounded (F and G) cells was carried out. In
(D) and (F), the levels of DNA are normalized to input. Columns are means ± SD of triplicates from a representative experiment.
(H) qRT-PCR analysis of Dll4 mRNA from control cells exposed for 10 hr to Wnt3a. After stimulation, Dll4 is upregulated to a level comparable to b-catenin GOF.
Columns are mean ± SD of triplicates from a representative experiment.
(I) Luciferase reporter assay. Luciferase activity was induced by control cells activation with Wnt3a (for 10 hr) and b-catenin GOF mutation. Point mutation of the
TCF-b-catenin binding sites in the Region 2 of the Dll4 promoter significantly reduce the luciferase activity. Columns are mean ± SD of triplicates from a repre-
sentative experiment.
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Wnt and Notch signaling pathways act in concert during embryo
development in patterning processes and in cell fate decisions946 Developmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier I(Clevers, 2006; Phng and Gerhardt, 2009). Although the
relevance of these two signaling systems is undoubted, the
molecular mechanisms that mediate their reciprocal regulation
are still not understood completely. We report that sustainednc.
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severe alterations in the development of the vascular system.
The link between these alterations and high or uncontrolled
Notch signaling is supported by several evidences: (1) in b-cate-
nin GOF mutants, Dll4 and the downstream effectors are strongly
increased in the embryo, in freshly isolated b-catenin GOF
embryonic ECs and in b-catenin GOF cultured ECs—in contrast,
freshly isolated ECs from LOF b-catenin embryos express
decreased amounts of Dll4 and Notch effectors; (2) increased
Notch nuclear signaling on b-catenin GOF mutation was
detected in the mutant embryos and cultured cells; (3) the
morphogenetic defects described in the b-catenin GOF mutants
were comparable, at least in part, to those described when
Notch signaling was increased by Dll4 upregulation in vivo,
including lack of vascular remodeling in the yolk sac and in the
head, impaired ECs migration, altered elongation of the interso-
mitic vessels, defects in branching, and loss of arterial-venous
identity causing AV shunts leading to bypass circulation (Carlson
et al., 2005; Trindade et al., 2008); and (4) DAPT treatment
partially reverted the cellular and vascular phenotype.
To better understand the molecular basis of b-catenin and Dll4
interaction and to exclude indirect effects due to altered blood
flow or organ perfusion, we focused on cultured b-catenin
GOF mutant ECs. These cells showed increased Notch signaling
and functional alterations similar to those reported for cells
expressing a GOF mutant of Notch (Trindade et al., 2008). These
include defects in actin organization and elongation, sprouting
activity, upregulation of lamellipodia and abrogation of filopodia.
DAPT treatment of b-catenin GOF mutant cells reverted signifi-
cantly this phenotype.
Besides Notch activation, b-catenin stabilization may act
through other pathways such as modification of junction organi-
zation and increase in cell-to-cell adhesion strength (Cattelino
et al., 2003). Although we cannot fully rule out this possibility,
the effect on cell migration and Dll4 expression are blocked by
a dominant-negative mutant (dnTCF4) that inhibits only b-cate-
nin transcriptional activity without modifying its recruitment
and activity at junctions. Moreover, a b-catenin mutant (LefDN-
bCTA) with strong transcriptional activity but unable to bind
cadherins, can reproduce the effect of inhibition of cell sprouting
whereas a mutant that is able to link cadherins but unable to
translocate to the nucleus (DC-Far) is inactive. Finally ChIP and
luciferase reporter analysis showed b-catenin binding to Dll4
promoter in parallel with its upregulation.
b-catenin can also modulate the expression of other genes
that may contribute to the observed embryo phenotype. This
cannot be excluded and deserves further investigation; however,
a significant part of the vascular defects detected in this study
seems to be comparable to those observed in Dll4 sustained
expression in vivo. This aspect and the extensive set of data dis-
cussed above make us rather confident that activation of the
Notch system contributes at least to a good extent to the
observed vascular phenotype in early embryo.
These data introduce what we believe to be a novel and impor-
tant level of regulation of vascular angiogenesis and endothelial
specification mediated by the cross talk between Wnt and Notch
signaling pathways. In a previous work (Phng et al., 2009)
reported that Notch can upregulate b-catenin signaling through
induction of Nrarp. This factor acts as a feed back mechanismDevelby limiting Notch on one side while upregulating Wnt signaling
on the other. The final result of loss of Nrarp in vivo is vascular
regression. Therefore, Wnt and Notch pathways can reciprocally
modulate each other by induction of activators or repressors.
Jag1, which is the second Notch ligand present in ECs, can
antagonize Dll4 activity in postnatal retina (Benedito et al.,
2009). Jag1 was found to be upregulated by b-catenin signaling
in non-ECs (Estrach et al., 2006). However, in this study we found
only very modest changes in the expression of this ligand in the
embryo suggesting that, at early stages of vascular develop-
ment, b-catenin signaling is switching the equilibrium in favor
of Dll4.
In our experimental system, we amplified b-catenin signaling
by maintaining high levels of the stabilized protein during
vascular development. However, other data suggest that wild-
type b-catenin signaling is important also in physiological
vascular morphogenesis. In controls embryos, we were able to
detect b-catenin signaling in several types of developing vessels.
Cultured control ECs show increased nuclear b-catenin and
signaling during migration. In the absence of b-catenin quite,
a few vascular regions such as the perineural vascular plexus
or retina vasculature present altered morphology. Furthermore,
b-catenin signaling was shown to be required for brain angiogen-
esis and for the development of a stable vasculature (Cattelino
et al., 2003; Daneman et al., 2009; Liebner et al., 2008; Lobov
et al., 2005; Stenman et al., 2008).
The observations reported here also show that, surprisingly,
activation of b-catenin signaling has different consequences de-
pending on the stage of vascular development in the embryo.
Activation of bcatenin does not modify arteriovenous specifi-
cation in the late embryo or in the postnatal retina. In other cell
systems, canonic Wnt signal controls progenitor cell expansion
and lineage decision in early embryo in a temporally regulated
way (see Clevers [2006] and Grigoryan et al. [2008]). Wnt
signaling plays different and sometimes even opposite activities
at different stages of embryo development (Ueno et al., 2007;
Grigoryan et al., 2008). From E14.5 arteriovenous differentiation
of endothelial cells is largely completed (for review, see Oliver
and Srinivasan, 2010) and this could explain why late activation
of b-catenin expression is no longer affecting vascular specifica-
tion.
In cultured ECs, b-catenin translocation to the nucleus and
Notch signaling is stronger in cells at the migrating front. This
is detectable already in wild-type endothelium and is more
evident in cells expressing b-catenin GOF mutation. This
suggests that, because migrating cells have weaker and partially
dismantled junctions, b-catenin interaction with cadherins is
reduced in strength and the protein may be released in the cyto-
plasm and translocate to the nucleus. Taddei et al. (2008)
showed that b-catenin signaling is increased in sparse cells as
compared to confluent stable cell monolayers. Consistently,
b-catenin binding to Dll4 promoter is higher in control wounded
cell monolayers as compared to confluent cells and this parallels
the increase in Notch signaling detected in these cells.
In conclusion, our study introduces canonical Wnt signaling as
an important pathway in modulating endothelial differentiation
and vascular development in the embryo. We propose that
when ECs are activated by canonical Wnt signaling, b-catenin
translocates to the nucleus and transcriptionally upregulatesopmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier Inc. 947
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act in concert to determine cell fate and a complex system of
activators and feedback inhibitors are needed to finely tune




The following transgenic mouse strains were used: b-cateninlox/lox (Brault et al.,
2001), b-cateninlox(ex3)/lox(ex3) (Harada et al., 1999), BAT-gal (Maretto et al.,
2003), ephrin-B2 (Wang et al., 1998), EphB4 (The Jackson Laboratory) (Gerety
et al., 1999), and TNR1 (The Jackson Laboratory) (Duncan et al., 2005). b-cat-
enin LOF embryos were generated as described (Cattelino et al., 2003). GOF
embryos were generated by mating mice homozygous for the b-catenin
exon 3 floxed allele (b-cateninlox(ex3)/lox(ex3)) with Tie2-Cre (Kisanuki et al.,
2001) or VE-Cadherin-Cre (Alva et al., 2006) heterozygous mice, to produce
b-cateninDex3/wt/Cre+ and b-cateninlox(ex3)/wt/Cre mice. All mouse strains
were backcrossed into the C57Bl/6J background.
Notch signaling was inhibited by subcutaneously injection of 100 mg/kg
DAPT (Alexis Bioscience) dissolved in 10% ethanol and 90% corn oil. DAPT
solution was injected twice, at E7.5 and E8.5, in b-cateninlox(ex3)/lox(ex3)/Tie2-
Cre pregnant animals and the embryos were dissected 24 hr later at E9.5.
All experiments were carried out in accordance with the guidelines established
in the Principles of Laboratory Animal Care (directive 86/609/EEC) and
approved by the Italian Ministry of Health.
Immunohistochemistry and qRT-PCR
Embryos were dissected in PBS, fixed in 4% paraformaldehyde overnight, and
used for whole-mount immunostaining as previously described (Cattelino
et al., 2003; Liebner et al., 2004).
Individual control and mutant embryos were dissected in ice-cold PBS.
Total mRNA was isolated with the RNeasy Mini Kit (QIAGEN) and 1 mg reverse
transcribed with random hexamers (High-Capacity cDNA Archive Kit, Applied
Biosystems) according to the manufacturer’s instructions. For the isolation of
embryonic ECs, embryos were digested with collagenase type I (Roche) for
30 min at 37C. The ECs were then separated using Dynabeads (Invitrogen)
coated with PECAM antibody (BD Transduction) and RNA isolated by extrac-
tion with TRIzol (Invitrogen). cDNA synthesis and qPCR analysis were carried
out as described in Taddei et al. (2008).
Cell Culture, Wound Healing Assay, and Immunofluorescence
ECs were isolated from E9.5 embryos b-cateninlox(ex3)/wt/Cre, cultured and
immortalized as described previously (Cattelino et al., 2003). The adeno-vector
expressing Cre recombinase was used to obtained ECs line b-cateninDex3/wt
(GOF). As control ECs were infected with adeno-vector expressing GFP.
In some experiments cells were exposed to conditioned medium (CM) of
L-cells, producing Wnt3a as described (Liebner et al., 2008). To define optimal
conditions for cell activation, two CM dilution (1:2 and 1:10) have been used for
different times of incubation (4, 10, 24, 48, and 72 hr). Dll4 was upregulated in
a concentration and time-dependent way and the optimal condition of 1:2 dilu-
tion for 10 hr was selected for further experiments.
Wound assay and immunofluorescence experiments have been described
previously (Cattelino et al., 2003).
ChIP Assay
ChIP assay was carried out as described previously (Taddei et al., 2008).
Luciferase Reporter Assay
A 3.7 kb fragment of the mouse Dll4 promoter (3631/+76) subcloned in the
pGL3 basic vector was kindly provide by T. Kume (Northwestern University
School of Medicine, Chicago). The Dll4-mut was generate to mutate the
TCF-b-catenin binding site TGGGGGACAAAGAGAGA to TGGGGGACCAAGA
GAGA using QuickChange Site-Directed Mutagenesis Kit (Stratagene).
Control and GOF cells were transfected in 6-well plates using Lipofectamine
2000 (Invitrogen) and 48 hr posttransfection luciferase activity was measured.948 Developmental Cell 18, 938–949, June 15, 2010 ª2010 Elsevier IEach experiment was repeated three times with each reaction mixture in
triplicate.
More details of the Experimental Procedures are reported in the indicated
references and in Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two movies, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.devcel.2010.05.006.
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